Candid On Cancer: Interview with Penn Medicine's Dr. Robert Vonderheide - Impact of the ACC

Penn Medicine's Dr. Robert Vonderheide, Director of the Abramson Cancer Center, discusses the FDA-approved cancer therapies developed at Penn Medicine that are now available to patients worldwide. 

Twitter @PennMDForum


March 1, 2023

Created by

Penn Physician VideoLink

Related Presenters

Robert Vonderheide, MD, DPhil

Robert Vonderheide, MD, DPhil

Medical Oncology

Director of the Abramson Cancer Center
John H. Glick Abramson Cancer Center Professor

View full profile